Ray Huang, head of Asia and principal engineer with Exponent, provides an update on the progress of factories in Asia and elsewhere in resuming full operations — and discusses the obstacles that might stand in the way.
Vito Calabretta, senior vice president of global operations with Tecsys, relates how supply chains are adjusting to the coronavirus pandemic, and how they might be permanently changed when it's over.
The Food and Drug Administration had to walk back testimony by an official at a Senate hearing last week after he downplayed the scale of China’s dominance of the drug supply chain in the U.S.
As companies struggle to adapt to disruptions caused by the coronavirus pandemic and other unanticipated factors, they’re finding value in the deployment of a digital twin.
Faith in existing enterprise systems, protocols and technology has been severely tested during the course of the COVID-19 pandemic. How should we adapt?